Document is current

Article History

Received: 22 July 2024

Accepted: 15 September 2024

First Online: 29 October 2024

Declarations

:

: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Conflicts of Interest G.I. Consultancy and Honoraria: Novartis, Roche, Kite/Gilead, Bristol-Myers Squibb, Abbvie, Janssen, Sandoz, Miltenyi, AstraZeneca.P.S. Honoraria, Advisory/Consultancy from Janssen, Roche, BMS, Abbvie, AstraZeneca, Chugai; Novartis and Kite/Gilead.K.R. Kite/Gilead: Research Funding, Consultancy, Honoraria and travel support; Novartis: Honoraria; BMS/Celgene: Consultancy, Honoraria; Pierre-Fabre: travel support.M.G. Consultancy/advisory: Novartis, Kite/Gilead, BMS, MSD, Pierre Fabre.AC.C. Honoraria: Novartis, Gilead, Bristol-Myers, Abbvie.A.M. Consulting fees: Takeda, BMS, Merck, Jazz Pharma, Sanofi. Research fundings: Gilead/Kite.R.H. Honoraria (Gilead, Janssen, Novartis, Celgene, MSD), Travel expenses (Gilead, Janssen).JL.R-H: Honoraria for lectures, consulting and advisory boards from Johnson&Johnson, Kite/Gilead, Novartis, BMS and Sanofi. Travel grants from Johnson&Johnson, BMS, Amgen, Kite/Gilead. Served on a Speakers’ Bureau for BMS, Johnson&Johnson, Kite/Gilead, Novartis, BMS, Amgen and Pfizer.A.S. Honoraria: Takeda, BMS/Celgene, MSD, Janssen, Amgen, Novartis, Gilead Kite, Sanofi, Roche, GenMab, Abbvie, Jazz Pharmaceuticals. Consultancy: Takeda, BMS/Celgene, Novartis, Janssen, Gilead, Sanofi, GenMab, Abbvie. Speaker’s Bureau: Takeda. Research Support: Takeda. Non-profit organizations: President of the EBMTA.M.G-S. Honoraria and/or consulting fees: Roche, BMS, Takeda, Janssen, Kyowa Kirin, Gilead / Kite, Incyte, Lilly, Miltenyi, Ideogen, Genmab, Abbvie, Sobi, Astra-Zeneca, GSK.M.K. Consulting and lectures: Gilead, Jazz, Pfizer.M.S. receives industry research support from Amgen, Bristol-Myers Squibb/Celgene, Gilead, Janssen, Miltenyi Biotec, Morphosys, Novartis, Roche, Seattle Genetics, and Takeda, and serves as a consultant/advisor to AvenCell, CDR-Life, Ichnos Sciences, Incyte Biosciences, Janssen, Molecular Partners, and Takeda. She serves on the speakers’ bureau at Amgen, AstraZeneca, BMS/Celgene, Gilead, GSK, Janssen, Novartis, Pfizer, Roche, and Takeda.A.K. Honoraria/ad board from Kite/Gilead, Roche, BMS, Novartis, Abbvie.E.B. Honorarium/Ad Board/Safety Review Committee: Kite/Gilead, Bristol Myers Squibb, Novartis, Pfizer, Incyte, ADC Therapeutics, Roche, Takeda, Daiichi Sankyo, Cellectis, Innate Pharma. Personal fees/Travel support: Kite/Gilead, Bristol Myers Squibb, Novartis, Pfizer, Takeda, Abbvie, Roche. Research funding: Amgen, BMS.P.B. Allogene: Honoraria; Amgen: Honoraria; BMS: Honoraria; Kite/Gilead: Honoraria; Janssen: Honoraria; Jazz Pharmaceuticals: Honoraria; Miltenyi: Honoraria; Novartis: Honoraria; Nektar: Honoraria.P.A. Consulting/advisory: Roche, Genmab, Janssen, BMS, AbbVie, AstraZeneca, BeiGene; Honoraria: Roche, Genmab, Janssen, BMS, AbbVie, AstraZeneca, Gilead, Incyte.